These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38880226)

  • 21. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
    Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
    Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y; Guan Y; Zhang X
    Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C; Ren Q; Deng J; Wang S; Ren L
    Biomed J; 2024 Aug; 47(4):100664. PubMed ID: 37774794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma.
    Guo S; Chen F; Li L; Dou S; Li Q; Huang Y; Li Z; Liu W; Zhang G
    J Adv Res; 2024 Jul; 61():165-178. PubMed ID: 37619934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
    Qi L; Yin Y; Sun M
    Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1.
    Chang Y; Cui M; Fu X; Zhang L; Li X; Li L; Wu J; Sun Z; Zhang X; Li Z; Nan F; Yan J; Zhang M
    Cancer Biol Ther; 2019; 20(1):31-41. PubMed ID: 30299211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
    Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
    Zhang CP; Huang XY
    Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.
    Pan X; Hong X; Li S; Meng P; Xiao F
    Exp Mol Med; 2021 Jan; 53(1):91-102. PubMed ID: 33420414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1.
    Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q
    Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
    Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nuclease and Tudor domain-containing protein 1 mRNA.
    Li N; Wei J; Zhang Q; Zhang Q; Liu B
    Anticancer Drugs; 2023 Jun; 34(5):627-639. PubMed ID: 36730541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. m
    Wu X; Fu M; Ge C; Zhou H; Huang H; Zhong M; Zhang M; Xu H; Zhu G; Hua W; Lv K; Yang H
    Mol Neurobiol; 2024 Aug; 61(8):5418-5440. PubMed ID: 38193984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
    Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
    J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.